Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Jazz Pharma Plc (JAZZ)

Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
3 Healthcare Stocks Walking a Fine Line

3 Healthcare Stocks Walking a Fine Line

COLL : 35.79 (+0.48%)
JAZZ : 182.07 (+0.03%)
BDX : 162.49 (+1.39%)
Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why

Jazz Pharmaceuticals (JAZZ) Stock Trades Up, Here Is Why

JAZZ : 182.07 (+0.03%)
Jazz: Q4 Earnings Snapshot

Jazz: Q4 Earnings Snapshot

JAZZ : 182.07 (+0.03%)
Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales

Jazz Pharmaceuticals (NASDAQ:JAZZ) Surprises With Q4 CY2025 Sales

JAZZ : 182.07 (+0.03%)
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2025 Financial Results and Provides 2026 Financial Guidance

– Record total revenues of $4.3 billion in 2025 (+5% YoY) and $1.2 billion (+10% YoY) in 4Q25 –

JAZZ : 182.07 (+0.03%)
Jazz Pharmaceuticals Earnings: What To Look For From JAZZ

Jazz Pharmaceuticals Earnings: What To Look For From JAZZ

JAZZ : 182.07 (+0.03%)
Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences

DUBLIN , Feb. 17, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the following investor conferences:

JAZZ : 182.07 (+0.03%)
1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off

JAZZ : 182.07 (+0.03%)
ELV : 299.04 (+2.39%)
FBRT : 9.10 (+1.45%)
1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid

1 Cash-Producing Stock with Impressive Fundamentals and 2 We Avoid

JAZZ : 182.07 (+0.03%)
ZS : 158.36 (+3.04%)
NVST : 25.51 (+1.96%)
Jazz Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Tuesday, February 24, 2026

DUBLIN , Feb. 10, 2026 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced its fourth quarter and full year 2025 financial results will be reported on February 24, 2026, after...

JAZZ : 182.07 (+0.03%)

Barchart Exclusives

NVIDIA Just Announced NemoClaw to Make OpenClaw Safer as ‘Lobster’ AI Agent Craze Raises Security Alarms
NVIDIA's new security stack addresses privacy concerns for the "fastest-growing open source project in history" as Chinese users spawn a cottage industry around AI assistant installation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar